PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹156 Cr | ₹176 Cr | ₹437 Cr | ₹548 Cr | ₹467 Cr |
What is the latest Contingent Liabilities ratio of PFIZER ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹156 Cr |
| Mar2024 | ₹176 Cr |
| Mar2023 | ₹437 Cr |
| Mar2022 | ₹548 Cr |
| Mar2021 | ₹467 Cr |
How is Contingent Liabilities of PFIZER Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹156 Cr | -11.64 | |
| Mar2024 | ₹176 Cr | -59.62 | |
| Mar2023 | ₹437 Cr | -20.37 | |
| Mar2022 | ₹548 Cr | 17.47 | |
| Mar2021 | ₹467 Cr | - | |
Compare Contingent Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹24,245.4 Cr | -0.2% | 4.7% | -5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,248.0 Cr | 1.8% | 2.7% | -11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,177.0 Cr | -0.6% | 7.7% | 9.4% | Stock Analytics | |
| CIPLA | ₹132,898.0 Cr | 4.9% | 6.7% | 7.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,428.0 Cr | 2.4% | -1% | 4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,818.0 Cr | 3.2% | -1.7% | -4.5% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -0.2% |
4.7% |
-5.7% |
| SENSEX | 2.4% |
2.3% |
4.4% |
You may also like the below Video Courses